Moderna stock surges as melanoma vaccine trial shows "landmark moment"

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.

• Aug 19

Moderna says its experimental vaccine prevented melanoma from returning or spreading

Moderna and Merck, its drug development partner, said the novel treatment prevented melanoma from returning or spreading in a study of high-risk melanoma patients.

• Aug 19

FDA approves new treatment for advanced melanoma

Dana-Farber and Mass General Hospital are offering a new therapy, which uses a patient's own tumor cells to fight melanoma.

• Jul 28

New technology helps doctors track moles that may be melanoma

The machine uses 26 cameras to photograph and patient and then creates a three-dimensional avatar, allowing doctors to track and examine moles.

• Aug 5, 2025

Why skin cancer survival rates are lower among people of color

According to the Melanoma Research Alliance, people of color are up to four times more likely to be diagnosed with advanced" melanoma. WBZ-TV’s Dr. Mallika Marshall reports.

• May 23, 2025

Moderna vaccine could help patients in later stages of melanoma

Melanoma patients in the later stages of the disease may soon have another treatment option.

• Dec 14, 2023

Moderna working on melanoma vaccine

WBZ-TV's Dr. Mallika Marshall reports.

• Dec 14, 2023